Navigation Links
Novel in Medical News

Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum

OLDSMAR, Fla., Aug. 6 /PRNewswire-FirstCall/ -- Cryo-Cell International, Inc. (OTC Bulletin Board: CCEL), one of the largest and most established leaders in stem cell innovation, will present data on the proliferative ability of stem cells found in menstrual blood (known as Men...

Bellicum Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial of Novel Vaccine for Patients With Advanced Prostate Cancer

HOUSTON, Aug. 6 /PRNewswire/ -- Bellicum Pharmaceuticals, Inc. today announced dosing of the first patient in a Phase I/II clinical trial of BP-GMAX-CD1, a novel pharmacologically regulated dendritic cell vaccine for the treatment of prostate cancer. The disease-specific trial is be...

Nfocus Neuromedical Announces European Approval for Novel Guiding Catheter at Society of NeuroInterventional Surgery

PALO ALTO, Calif., July 29 /PRNewswire/ -- Nfocus Neuromedical Inc. announced today at the 6th Annual Meeting of the Society of NeuroInterventional Surgery ( www.snisonline.org ) that Nfocus has earned a European CE Mark approval for its novel guiding catheter, the Echo(TM) Di...

Labopharm receives complete response letter from the U.S. FDA for novel antidepressant

LAVAL, QC, July 20 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced it has received a complete response letter from the U.S. Food and Drug Administration (FDA) for the new drug application (NDA) submission of its novel formulation of the antidepressant trazodone....

American Society of Hematology awards grants to encourage novel medical training programs

(WASHINGTON, July 13, 2009) The American Society of Hematology (ASH) announces that Ellis J. Neufeld, MD, PhD, of Harvard Medical School, Thomas Shea, MD, of University of North Carolina at Chapel Hill, and Alvin Schmaier, MD, of Case Western Reserve University in Cleveland, will each receive ASH...

Transdel Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment

LA JOLLA, Calif., July 8 /PRNewswire-FirstCall/ -- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP) a specialty pharmaceutical company focused on developing non-invasive, topically administered products, today announced they have successfully completed the enrollment of patients in their ...

Gene's novel role may provide key to treating liver and neurodegenerative diseases

Scientists at Singapore's Bioprocessing Technology Institute (BTI) have made a novel discovery about how the gene, "Fas-apoptosis inhibitory molecule" (FAIM), protects both immune and liver cells from apoptosis, or programmed cell death. Their research is published in the current journal Cell...

Study shows PET can measure effectiveness of novel breast cancer treatment

RESTON, Va.A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended. Researchers successfully used PET and a specially-dev...

Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases

Results Demonstrate Positive Proof of Mechanism SAN DIEGO, June 30 /PRNewswire/ -- Amira Pharmaceuticals, Inc. announced today initial positive data from a Phase 1 clinical study of AM211, the company's oral selective antagonist of the DP2 (also known as CRTH2) receptor. The interim resu...

Scientists Gather to Discuss Novel Uses of Caliper Life Sciences' Discovery Platforms and Technology

- Recent 'Innovation for Experimentation' Series Attracts Over 350 Attendees - HOPKINTON, Mass., June 29 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, reports that more than 350 ...

Study pinpoints novel cancer gene and biomarker

BOSTON--Dana-Farber Cancer Institute scientists' discovery of a cancer-causing gene the first in its family to be linked to cancer demonstrates how the panoramic view of genomics and the close-up perspective of molecular biology are needed to determine which genes are involved in cancer and whic...

NTU and Sembcorp to jointly explore novel waste water treatment technology

Nanyang Technological University's Nanyang Environment and Water Research Institute (NTU-NEWRI) and Sembcorp Industries (Sembcorp) signed an agreement today to jointly explore the application of a new system for the treatment of complex industrial wastewater. Under the agreement, Sembcorp and...

Transcend Medical Raises $35 Million Series B Round Towards Development of Novel Glaucoma Treatment

MENLO PARK, Calif., June 22 /PRNewswire/ -- Transcend Medical, Inc., an ophthalmic device company dedicated to delivering breakthrough advances in the treatment of glaucoma, announced today that it has closed a $35 million Series B round and is continuing the rapid development of its Transcend CyP...

New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimer's Disease Market

Sales of Acetylcholinesterase Inhibitors, Which Currently Dominate the Market, Will Decline by $1 Billion from 2008 to 2018, According to a New Report from Decision Resources WALTHAM, Mass., June 17 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for...

FluoroPharma to Present Phase I Study Results of Novel Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI) Tracer

BOSTON, June 15 /PRNewswire/ -- FluoroPharma Inc., a company developing breakthrough PET molecular imaging agents, announced that it will present Phase I data relating to the safety, dosimetry, and pharmacokinetics in human subjects of BFPET, its novel 18-F labeled PET tracer for myocardial perfus...

Animal model for schizophrenia identifies a novel approach for treating cognitive impairments

Philadelphia, PA, 9 June 2009 - Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of ...

Health Department Reports Pennsylvania's First Death Due to 2009 Novel Influenza A/H1N1 Virus

Public Urged to Take Same Steps They Would During Any Flu Outbreak HARRISBURG, Pa., June 4 /PRNewswire-USNewswire/ -- The first death in Pennsylvania associated with 2009 Novel Influenza A/H1N1 was reported today in Berks County. Currently, the state has 269 confirmed cases and 101 probable c...

Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer

RARITAN, N.J., June 4 /PRNewswire/ -- Ortho Biotech Oncology Research & Development, a unit of Centocor Research & Development, Inc., today announced that it has entered into a five-year Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), with S...

Pitt melanoma researchers present novel findings at ASCO

PITTSBURGH, May 30 Researchers from the University of Pittsburgh Cancer Institute (UPCI) have identified eight genes that help predict a melanoma patient's response to treatment. The new findings are being presented at the 45th annual meeting of the American Society of Clinical Oncology (ASCO), M...

Kyowa Hakko USA Announces GRAS Self-Affirmation for Novel Brain Health Ingredient Cognizin(R) Citicoline

NEW YORK, May 28 /PRNewswire/ -- Kyowa Hakko U.S.A., Inc. (Kyowa Hakko USA), the wholly owned subsidiary of Kyowa Hakko Bio Co., Ltd., (Kyowa), has announced it has completed GRAS (Generally Recognized As Safe) self-affirmation for the novel brain health ingredient Cognizin(R) Citicoline. Co...

A novel marker of colorectal carcinoma

The colorectal cancer is thought to be resulted from a combination of environmental factors, diet, lifestyle, chronic inflammation and accumulation of specific genetic alterations. The pathogenesis and development of colorectal cancer involve multi-genes and multi-steps. TSPAN1 (GenBank Accession ...

The Launch and Uptake of More Than 20 Novel Drugs Over The Next 10 Years Will Drive $12.5 Billion Growth in the Type 2 Diabetes Market

Commercial Potential of Market is Reflected in Burgeoning Pipeline of More than 400 Drugs in Development, According to a New Report from Decision Resources WALTHAM, Mass., May 20 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and ...

Results of phase III study on Labopharm's novel antidepressant published in Psychiatry (Edgemont) Journal

- Company to Also Present Clinical Data at Upcoming Scientific Meeting - LAVAL, QC, May 19 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced the publication of Extended Release Trazodone in Major Depressive Disorder:...

Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer

Preclinical Study is Subject of Upcoming ASCO Presentation BELLEVUE, Wash., May 18 /PRNewswire/ -- Light Sciences Oncology, Inc. (LSO) today announced that a new preclinical study has yielded evidence that the company's novel light-activated drug Aptocine(TM) (formerly Litx(TM)) may enhance a...

ImQuest BioSciences and Arisyn Therapeutics Introduce Novel New HCV Therapeutic Agent at Hepatitis Conference

FREDERICK, Md., May 14 /PRNewswire/ -- ImQuest Bio and Arisyn jointly presented important new results on ATI-0810 (Formerly PG301029), a novel late stage inhibitor of hepatitis C virus (HCV) replication, at the 13th ISVHLD meeting held last week in Washington D.C. The presentation highlighted t...

Telesso Technologies wins Popular Science Invention Award for its novel peripheral IV catheter

Telesso Technologies Limited (ASX: TEO), a global healthcare company, announced today the FDA-approved guide wire-assisted peripheral IV catheter it is developing with Vascular Pathways, Inc., has been honored with the Popular Science Invention Award. "Telesso is pleased to receive another exci...

Medivation to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference

SAN FRANCISCO, May 13 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN ) today announced that David Hung, M.D., president and chief executive officer, will present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference on Wednesday, May 20 in New York. Dr. Hung will pr...

Ironwood and Forest to Present Additional Phase 2b Data for Novel Gastrointestinal Agent Linaclotide

- Data to be presented at Digestive Disease Week 2009 - CAMBRIDGE, Mass. and NEW YORK, May 12, 2009 /PRNewswire-FirstCall/ -- Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX ) today announced they will be reporting additional clinical data from their Phase 2b studies...

Positive Results for Ophthotech's Novel Therapy for Wet AMD - Study of Anti-PDGF and Anti-VEGF Therapy Shows Significant Neovascular Regression and Enhanced Visual Outcome

59% of patients showed 3-line gain (significant visual gain) and 100% neovascular regression FORT LAUDERDALE, Fla., May 4 /PRNewswire/ -- Ophthotech Corp. today announced positive results of a phase 1 clinical study evaluating E10030, its novel anti-platelet derived growth factor (anti-PDGF...

Fixed Dosed Combination Agents and Novel Antihypertensives Are Expected to Face Tougher Formulary Restrictions

Longitudinal Data Trends Suggest These Agents Will Face Greater Use of Step Therapy Restrictions and Less Access on Tier 2 on Commercial Health Plans, According to a New Report from HealthLeaders-InterStudy and Fingertip Formulary NASHVILLE, Tenn. and GLEN ROCK, N.J., April 28 /PRNewswire/ --...

Compendia Bioscience Announces Collaboration with MDS Pharma Services to Deliver Novel Solution for Oncology Drug Development

ANN ARBOR, Mich., April 28 /PRNewswire/ -- Compendia Bioscience today announced a strategic collaboration with MDS Pharma Services to deliver OncoPredictor(SM) -- a novel solution for improved cancer drug development. OncoPredictor(SM) combines MDS Pharma Services OncoPanel(TM) with Compendia Bio...

Ethicon Endo-Surgery Novel Investigational Notes and SSL Devices Featured in 15 Presentations at Sages

CincinNAti, April 22 /PRNewswire/ -- Ethicon Endo-Surgery today announced the company's novel, investigational* devices, including its NOTES Toolbox(TM), are featured in 15 studies being presented at the 2009 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting. ...

Singapore First in Southeast Asia to Use Novel Treatment for Sports and Musculoskeletal Injuries

Originally employed in dentistry, this method of accelerated tissue healing is showing its worth in soft-tissue repair, says one Singapore doctor. Singapore (PRWEB) April 14, 2009 -- It was first used by dental surgeons about 15 years ago to enhance wound healing of bon...

Mount Sinai researchers discover novel mechanisms that might causally link type-2 diabetes to Alzheimer's disease

A recent study by Mount Sinai faculty suggests that a gene associated with onset of type-2 diabetes also decreases in Alzheimer's disease dementia cases. The research, led by Dr. Giulio Maria Pasinetti, MD, Ph.D., The Aidekman Family Professor in Neurology, and Professor of Psychiatry and Geriatri...

A Decision Beyond Life and Death: Novel Examines Effects of Controversial Procedure on Patients, Their Families and Doctors

WATERLOO, Iowa, April 10 /PRNewswire/ -- "ETOP: Elective Termination of Pregnancy" ( published by AuthorHouse ) by Stephen L. Styron is a novel exploring the difficulties that some women and their families face when choosing to terminate a pregnancy. At County Memorial Hospital, a massive ...

Glissandra Skincare Inc. Launches Website Showcasing New and Novel Anti-Aging Skincare Products

Glissandra Skincare Inc. announces the launch of its website, Glissandra.com. The new website features an innovative line of anti-aging skincare products, and offers resellers the opportunity to enter a highly-profitable industry. (PRWEB) March 9, 2009 -- Glissandra Ski...

AFRAID TO GO HOME, A Novel About Violence Against Women, Released By Tristan/Isolde Publishing

REDONDO BEACH, Calif., March 3 /PRNewswire/ -- Tristan/Isolde Publishing, a new imprint devoted to the relationships between men and women, has released a new novel today, AFRAID TO GO HOME. AFRAID TO GO HOME, a 420 page paperback, is about a White, middle-class, educated, female executive w...

Endo Licenses Novel Pain Therapy from Grunenthal

CHADDS FORD, Pa., Feb. 27 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that it has licensed from Grunenthal the exclusive rights to develop and market the investigational drug axomadol in the United States and Canada. Axomadol is a patented new chemical entity d...

Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology

Dressing Offers a Highly Effective and Affordable New Option to Help Combat the Escalating MRSA Crisis PRINCETON, N.J., Feb. 27 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that its first BIOGUARD Ba...

Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention

LONDON, Feb. 24 /PRNewswire/ -- Early detection is the key focus of cancer diagnostics. Traditional testing methods such as immunoassay testing are facing fierce competition from evolving segments such as nucleic acid amplification technology (NAT) and immunohistochemistry testing. The abili...
Other Tags
(Date:4/18/2014)... twist to the story of how barnyard chickens came to ... the journal Proceedings of the National Academy of Sciences ... lived 200-2300 years ago in Europe, researchers report that just ... far different from the chickens we know today. , The ... modern domestic chickens -- such as their yellowish skin -- ...
(Date:4/17/2014)... trials to treat tuberculosis could be the basis for ... bacteria, fungal infections and parasites, yet evade resistance, according ... collaborators. , Led by U. of I. chemistry professor ... drug SQ109 attacks the tuberculosis bacterium, how the drug ... to malaria and how targeting multiple pathways reduces ...
(Date:4/17/2014)... study suggests that fish consumption advisories for expecting ... long-lived contaminants like persistent organic pollutants (POPs). ... researchers including University of Toronto Scarborough PhD student ... how different levels of environmental contamination, a mother,s ... in the body influenced exposure in her children. ...
Breaking Biology News(10 mins):Ancient DNA offers clues to how barnyard chickens came to be 2Multitarget TB drug could treat other diseases, evade resistance 2Fish consumption advisories fail to cover all types of contaminants 2
(Date:4/17/2014)... popular vaccine brands for children may not be the ... cost factors when choosing vaccines, driving the market toward ... a new study by University of Illinois researchers. , ... by numerous factors," says Sheldon H. Jacobson, a co-author ... and of mathematics at the U. of I. "In ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
(Date:4/17/2014)... New Rochelle, NY, April 17, 2014U.S. military personnel ... "blast plus impact" concussive traumatic brain injury (TBI) ... were evacuated for other medical reasons. Differences in ... and depression 6-12 months after injury are reported ... , a peer-reviewed journal from Mary Ann Liebert, ...
(Date:4/17/2014)... IL, April 17, 2014-- Colic affects about one in ... for numerous pediatric visits during the first several months ... colic symptoms was showing promise; however, the April 1, ... (BMJ2014;348:g2107; Sung, Valerie) reported on a study, "Probiotics and ... L reuteri for infant colic did ...
(Date:4/17/2014)... An international team led by researchers at UC ... which plays a key role in cell division, also ... is the first time the complex has been shown ... cyclin B1/Cdk1 an excellent target to control cellular energy ... research was published online today in the journal ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Dual role: Key cell division proteins also power up mitochondria 2
Other Contents